Citation: Y. Xu and Y. Zhu, Nano Adv., 2016, 1, 25−38. Magnetic nanoparticles (MNPs) have been extensively studied for their biomedical applications, especially in cancer diagnosis and therapy. Recent progresses in synthesis and modification of MNPs widen and promote their biomedical applications. MNPs could load drugs/genes for chemotherapy and gene therapy. Due to the hysteresis loss and/or Né el and Brownian relaxations of MNPs under an alternating magnetic field, MNPs could be thermo seeds for hyperthermia therapy. Also, MNPs could be contrast agent for magnetic resonance imaging (MRI). Furthermore, the combination of MNPs with functional components could be a multifunctional platform for diagnosis and therapy. In this review, we briefly summarize the mainly used methods to the synthesis and efficient surface engineering strategies of MNPs. Importantly, some recent progresses in MNPs-based cancer diagnosis and therapy are highlighted.
Introduction
Magnetic nanoparticles (MNPs) including magnetite Fe 3 O 4 , maghemite γ-Fe 2 O 3 , spinel-type ferro-magnets (MFe 2 O 4 , M = Mn, Ni, Co) and metal alloy (FeCo, FePt) have emerged as promising tools in biomedical application, especially in cancer therapy. 1, 2 Recent years, multifunctional platform with the combination of diagnostic probes and therapeutic agents (referred as theranostics) has attracted much attention. 3−5 Owing to the desired imaging sensitivity and therapeutic efficacy, multifunctional MNPs could precisely diagnose and effectively treat the disease. MNPs are considered to be the most promising agents for theranostics. 6, 7 In general, MNPs for potential applications in biomedical theranostics rely on the synthesis of high-quality MNPs as well as proper surface modification. A series of chemical methods, such as co-precipitation, 8−10 thermal decomposition, 11, 12 solvothermal 13−15 and microemulsion methods 16, 17 have been developed to synthesize mono-dispersed MNPs with controllable particle sizes. However, pure MNPs were hindered in biomedical application due to their nature drawbacks including the tendency to form aggregates in physiological environment and oxidation upon exposure to air. Also, aggregation may result in alternation of magnetic properties. Therefore, an appropriate surface modification is required to overcome these limitations, and thereby prolong their circulation time, minimize side effects to normal tissue, and finally reduce the total dose required. 18, 19 Currently, a variety of functional coatings, such as inorganic silica, organic molecules, surfactants, polymers and other functional components were widely used to modify MNPs, and thus drugs/genes and other therapeutic agents could conjugate on the carriers to form multifunctional theranostics platform.
In this review, we briefly summarized the most widely used MNPs synthesis methods and appropriate surface modification strategies of MNPs for biomedical theranostics. Importantly, we highlighted the applications of MNPs including hyperthermia, drug/gene delivery, magnetic resonance imaging (MRI) and multifunctional theranostics.
Synthesis of magnetic nanoparticles (MNPs)
For biomedical applications, MNPs are often required to have advantages including monodispersity, narrow size distribution, controllable particle size, and superior stability in aqueous solution. To date, a series of chemical methods were established to synthesize MNPs. Among them, the commonly used methods are co-precipitation, thermal decomposition, solvothermal and microemulsion reaction for the synthesis of high quality MNPs.
Co-precipitation
Co-precipitation is the most common and simplest method to synthesize magnetic nanoparticles. Typically, ferrous and ferric salts solution were added in alkaline aqueous under inert atmosphere at room temperature or at elevated temperature. The Fe 2+ /Fe 3+ ratio, the reaction temperature, the pH value and ionic strength of the media are the main factors to influence the quality of magnetic nanoparticles by co-precipitation method. 20, 21 A large scale of magnetic nanoparticles could be obtained by co-precipitation method, but the drawback lies in the hard control of particle size, shape and dispersity. Owning to the requirement of high dispersity of MNPs for biomedical applications, the researchers proposed to stabilize the MNPs with additives including polyvinyl alcohol (PVA), poly(ethylene glycol) (PEG), poly(acrylic acid) (PAA), citric acid, oleic acid, etc. 22−25
Thermal decomposition
MNPs with high monodispersity, uniform sizes and excellent magnetic properties are more likely to be synthesized by thermal decomposition of organometallic precursors in high-boiling organic solvents with the help of stabilizing surfactants. 11, 26, 27 Generally, the ratios of organometallic compounds, surfactant and solvent, the reaction temperature and time, are critical for the control of the size and morphology of MNPs. Sun et al. synthesized Fe 3 O 4 nanoparticles from the direct decomposition of iron (III) acetylacetonate. 28 The nanoparticles were obtained by mixing iron (III) acetylacetonate precursor with phenyl ether, 1, 2-hexadecanediol, oleic acid and oleylamine under nitrogen atmosphere, the Fe 3 O 4 nanoparticles with 4 nm in size could be obtained after refluxing the mixture for 30 min. Furthermore, they found that the sizes of Fe 3 O 4 nanoparticles could also be controlled from 3 to 20 nm by varying the reaction temperature and metal precursors. 27 Jana et al. synthesized the size-and shape-controlled magnetic oxide nanocrystals based on the pyrolysis of metal fatty acid salts. Nearly monodispersed Fe 3 O 4 nanocrystals with a size range of 3~50 nm could be synthesized. Moreover, the controllable shapes, including dots, rods and cubes, were achieved by varying the reactivity and concentration of the precursors. 29 
Solvothermal synthesis
Compared with thermal decomposition approach, solvothermal synthesis is more environmental friendly, since there is no need of toxic solvent during the process. The reaction was carried out in reactors or autoclaves where the pressure can be higher than 2000 pounds per square inch and the temperature can be above 200 °C. Li et al. reported the synthesis of monodispersed, hydrophilic, single-crystalline ferrite microspheres by solvothermal reduction method. 14 Ferric chloride hexahydrate (FeCl 3 · 6H 2 O), ethylene glycol, sodium acetate, and polyethylene glycol were mixed and stirred vigorously followed by sealing the mixture in a Teflon-lined stainless-steel autoclave. By heating the autoclave at 200 °C for 8-72 h, monodispersed magnetic microspheres with tunable sizes in the range of 200-800 nm were obtained. This method also could be applied to produce a series of ferrite MFe 2 O 4 microspheres.
Microemulsion synthesis
A microemulsion is a thermodynamically stable isotropic dispersion of two immiscible liquids, where the microdomain is stabilized by an interfacial film of surfactant molecules. 30 The MNPs were synthesized within the nanosized droplets, and thus T a b le 1. Comparison of various synthesis methods to magnetic nanoparticles.
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Ref. the nucleation, growth and further agglomeration of these MNPs were mostly determined by the molar ratio of water to surfactants. 25, 26 The comparison of synthesis methods mentioned above is briefly summarized in Table 1 .
Co-precipitation
Surface modification of magnetic nanoparticles
The surface modification could stabilize MNPs in physiological environment, protect the magnetic core against oxidation, enable facile chemical functionalization of MNPs, 34 and hence facilitate to promote their biomedical applications. A variety of biocompatible materials have been used to modify MNPs, such as inorganic silica, polymers and other functional components ( Figure 1 ).
Inorganic silica
Silica is one of the most widely used inorganic materials for coating MNPs. Silica shell could avoid the aggregation and oxidation of the magnetic core, and the further functionalization of silica shell could conjugate drug/gene molecules and other therapeutic agents. 35−37 Mesoporous silica shell offers high surface area and large pore volume for drug/gene delivery. 38, 39 Kim et al. reported the successful enwrapping of hydrophobic magnetic nanocrystals in uniform mesoporous spheres by a sol-gel reaction. Hydrophobic ligand-capped Fe 3 O 4 nanoparticles were firstly transferred to aqueous solution by capping with a secondary surfactant cetyltrimethylammonium bromide (CTAB), and then tetraethyl orthosilicate (TEOS) was used to form mesoporous silica shells. 40 Stöber process 41 and reverse microemulsion method 42 were also successful in preparing silica coated MNPs. More recently, Wu et al. dispersed ultrafine iron oxide nanoparticles within the channels of mesoporous silica nanoparticles and then loaded anticancer drugs into mesopores via a special metal-ligand coordination bonding. The resulting magnetic nanocomposite is promising for drug delivery and MRI diagnosis as T1-MRI contrast agent. 43 Solid silica was usually used for preparing hollow structure which could provide a large cavity for anticancer drug loaded. MNPs were firstly coated with solid silica, followed by mesoporous silica. And then the solid silica layer could be etched by hydrofluoric acid (HF) or alkaline substances (NaOH or ammonia) to form a large cavity. 44 Chen et al. developed a rattle-type magnetic core/mesoporous silica platform by selectively etching the solid silica layer in the magnetic core/solid silica/mesoporous silica nanoparticles, the loading capacity of the nanosystem could reach to 20% and loading efficiency was almost 100%. 45 Silica is robust, water-soluble, colloidally stable, photostable, and biocompatible and it provides better protection against the aggregation and toxicity. More importantly, MNPs coated with mesoporous silica provide sufficient area for anticancer drugs and genes to load.
Polymers
Polymers are often applied to improve the dispersity and stability of MNPs. Dextran, one of the most widely used polymer for coating MNPs because of its biocompatibility and biosafety. Importantly, dextran-coated iron oxide nanoparticles have been approved by FDA for MRI contrast agents. 46, 47 Dextran-coated MNPs can provide active sites for further tailoring these nanoparticles, and other biomedical applications such as drug delivery system were intensively studied by researchers. 48−50 Polyethylene glycol (PEG) is another kind of widely used synthetic polymer for the modification of MNPs, since PEG could improve the biocompatibility, prevent agglomeration and prolong blood circulation time of MNPs. 51−53 The excellent properties make PEG to be one of the utmost popular polymers for MNPs modification. Sun et al. reported a simple and efficient technique to synthesize PEGylated iron oxide nanoparticles (ION/PEG), and PEG played a role in controlling the nucleation and growth of iron oxide core. 23 The ION/PEG system was stable and suitable for tumor-specific imaging. Besides, some other application such as drug delivery system and hyperthermia based on PEG-functionalized MNPs were also reported. 54−56 Polyvinyl alcohol (PVA) is a type of hydrophilic, biocompatible and biodegradable polymer. There are many hydroxyl functional groups on PVA, which makes it easily complex with MNPs. PVA modified MNPs show an improved dispersity and the agglomeration of MNPs was prevented. 57−62 Studies indicated that PVA coated MNPs are suitable for drug delivery. 63 Other polymers, which are useful in the modification of MNPs, were summarized in Table 2 .
Other functional components
Gold exhibits good biocompatible as well as optical and electronic properties, and hence gold is often designed to form a multifunctional nanocomplex. 64, 65 Seed-mediated growth approach was commonly chosen to modify MNPs with gold nanoshells. Lee et al. developed multifunctional magnetic gold nanocomposites (MGNCs) for cancer diagnosis and therapy. 66 Gold nanolayer was deposited on magnetic nanocomposites via seed-mediated growth approach and then modified with PEG for the conjugation of a therapeutic antibody Erbitux (ERB). Dong et al. reported a facile strategy to develop magnetic core/gold shell structured nanocomposites with tunable dimensions. 64 Magnetic core coated with an Au nanoshell could easily obtain the tuned optical properties, and hence the potential imaging and photothermal therapy could be realized within this hybrid system. More recently, Chen et al. used polysiloxane-containing polymer to coat MNPs, and gold sulfide (Au 2 S) nanoparticles could be attached onto the MNPs/polymer nanoparticles through one-step surface modification. 67 The resulting magnetic core/gold shell nanocomposites showed highly integrated properties, allowing for the applications in cancer diagnosis and therapy. Similar with gold, quantum dots (QDs) are also widely used since its unique absorption and emission properties, photo stability and size dependent wavelength tenability. 68, 69 The combination of QDs with MNPs leads to an imaging-guided therapy system. 70, 71 Shibu et al. developed a kind of photouncaging nanoparticles (PUNPs) by the combination of MNPs and QDs, which could be a bimodal contrast agent for the combined MRI and NIR fluorescence imaging of melanoma cells and B6 mice. 72 Surface modification would influence the MNPs fate during the circulation time in the body, so appropriate modification could stabilize MNPs and significantly widen their biomedical applications. The coating materials should be biocompatible, low in toxicity, and provide some other functions during the applications. Besides those coating materials mentioned above, more materials which are suitable for the modification of MNPs were summarized in Table 2 .
Multifunctional MNPs for theranostics
MNPs possessing good physical characteristics with proper functionalization could ensure biocompatibility and endow specific targeting and delivery properties. MNPs are modified with a series of functional materials, such as silica, polymers and other optical materials, and then the modified MNPs are more suitable to serve as hyperthermia seeds, drug/gene delivery systems, and other therapy agents. Moreover, multifunctional diagnostic and therapeutic platform could be easily realized when MNPs are combined with other functional materials. Here, we further review some applications of MNPs in the fields of hyperthermia therapy, drug/gene delivery, MRI contrast agent, and multifunctional diagnostic and therapeutic.
Hyperthermia therapy
The idea of using MNPs as heat seeds for cancer hyperthermia therapy is not new, 115 but the main restriction in hyperthermia for cancer therapy is heating the tumor tissue without harming the surrounding normal tissues. Generally, a temperature between 42 and 48 °C was believed to kill a great number of cancer cells without damaging normal cells. 116, 117 MNPs possess the inherent property of generating heat under an alternating magnetic field (AMF) by the hysteresis loss and/or Né el and Brownian relaxations. 118 Hyperthermia treatment induced by MNPs was investigated by Chan et al. 119 and Jordan et al. 120 in 1993. Since then, various studies focused on optimizing the size, surface coating, composition and magnetic susceptibility of MNPs to improve the heating efficiency, and further widen the clinical applications of MNPs based hyperthermia. 115, 121, 122 MNPs with a higher magnetic heating efficiency (high specific loss power (SLP) values) were more useful in cancer hyperthermia treatment. In this section, we briefly summarized the efforts made by researchers from the following aspects: the particle size, surface coating, and composition were optimized to improve the SLP values. Particle size as the first aspect should be studied. Levy et al. found that the heating efficiency showed a maximum of 950 W/g for a 15 nm maghemite nanoparticles. 123 Gonzales-Weimuller et al. reported that the highest SLP value of 447 W/g was achieved for 14 nm iron oxide nanoparticles. 124 These studies indicated magnetic heating efficiency was size-dependent. Appropriate surface modification was also important when MNPs serve as hyperthermia seeds. 25, 125, 126 Bae et al. designed chitosan oligosaccharide-stabilized ferromagnetic iron oxide nanocubes (Chito-FIONs) for hyperthermia treatment of cancer. 127 The 30 nm sized oleic acid-capped FIONs were modified with l-3, 4-dihydroxyphenylalanine (DOPA) -conjugated chitosan oligosaccharide, and the SLP value of Chito-FIONs could reach 2614 W/g. When incubated with A549 cells, a remarkable cytotoxic effect of 78±9.6% could be obtained under an AMF. Furthermore, Chito-FIONs could greatly suppress the growth of tumor by application of an AMF.
Besides iron oxide nanoparticles, spinel-type ferro-magnets such as MnFe 2 O 4, and CoFe 2 O 4 nanoparticles were also widely used as hyperthermia seeds due to their higher magnetic susceptibility. Lee et al. systematically studied the magnetic heating efficiency related with size and composition. 128 was used to test the hyperthermia therapy efficacy. U87MG human brain cancer cells were injected and an alternating current (AC) magnetic field of 500 kHz and 37.3 kA/m was applied for 10 min. After 18 days treatment, the tumors were completely eliminated while the tumors in control groups were several fold larger ( Figure 2 ). The study indicated that the magnetic heating efficiency was significantly impacted by the composition of MNPs. Similarly, Liu et al. reported the 18 nm MnFe 2 O 4 nanoparticles loaded within the amphiphilic copolymer (PBMA-g-C12) showed good biocompatibility and was a potential hyperthermia mediator. 129 
Drug delivery
An efficient drug delivery system is significantly important in cancer therapy. The delivery of anticancer drugs and genes (cargos) is often influenced by three factors: the good biocompatibility and low toxicity of the carriers, difficulty to deliver cargos to the desired location, and difficulty to control the release behavior of cargos. MNPs are suitably designed as drug delivery carriers due to their biocompatibility, low toxicity and easy modification with a serious of materials. Moreover, the therapeutic agents could either conjugate on the surface of MNPs or be encapsulated into the coating materials of MNPs. 1, 23, 34, 45, 58, 66, 72, 130 What is more, MNPs-based drug delivery system could deliver therapeutic agents to specific tissues by the application of external magnetic field guidance, so a high drug concentration could be formed at the diseased sites and a lower overall dose was used. 131−134 The external magnetic field is used for not only guiding MNPs to the target sites, but also inducing heat which is proved as an efficient trigger for the release of therapeutic agents. 135−138 The feasibility of the magnetic field triggered drug delivery has been well studied. For instance, Thomas et al. encapsulated zinc-doped iron oxide nanocrystals (ZnNCs) within mesoporous silica nanoparticles, and loaded drugs in mesoporous channels. They found that this MNPs-based drug delivery system could induce local heating when applying an oscillating magnetic field, which promote drug release effect. 137 Also, more cancer cells were killed due to the drug release and local heat upon exposure to magnetic field. Our group has also designed DNA-capped core-shell nanocarriers (Fe 3 O 4 @SiO 2 ) for anticancer drug (DOX) delivery. 138 MNPs-based nanocarriers were able to increase temperature to 50 °C within 10 min under a frequency of 409 kHz and magnetic field strength of 180 Gauss, and almost 50% of DOX could be released from the nanocarriers within 8 h at the critical temperature, but less DOX could be released at 37 o C. Lee et al. developed a magnetothermally responsive DOX-encapsulated drug delivery system (DOX@SMNPs), 139 which is composed of DOX and four different molecular building blocks (Figure 3) . The DOX@SMNPs could be delivered to the target site and an acute drug could be released in tumor site under the help of AMF (500 kHz, 37.4 kA/m). Under the treatment of DOX and applied AMF, the tumor was effectively inhibited, and the group treated with a double injection (day 0 and day 7) of DOX@SMNPs with AMF showed continued and effective inhibition of tumor growth ( Figure 3D ). The external magnetic field was important in MNPs based drug delivery system, and was proved as an efficient trigger for the release of therapeutic agents. Since MNPs could generate heat when an external magnetic field applied, temperature-responsive chemical ingredients are attracted in MNPs based drug delivery system. Besides cappers mentioned above, a serious of temperature-responsive polymers were also popular in such design. 97, 98, 140−143 MNPs could also serve as gatekeepers during the drug delivery process. Giri et al. reported a magnetic responsive controlled-release delivery system where superparamagnetic iron oxide nanoparticles were used to serve as gate keeper. 144 Fluorescein could be encapsulated and the system can be magnetically directed to a site of interest, cell-produced antioxidants (e. g., dihydrolipoic acid) and an external magnetic field was used to trigger fluorescein release.
Gene therapy is another important cancer therapy strategy, and has been studied in clinic for a variety of cancer types. The upregulation or downregulation of genes in cancer cells would lead to uncontrolled cell growth. Transfection of a therapeutic gene (DNA and RNA) into specific cells is useful in precise cancer therapy. 145−147 However, this strategy was inhibited by the instability and short half-lives during the circulation of naked DNA and RNA. MNPs are attractive delivery platforms for genes because of their low toxicity, biocompatibility, imaging characteristics and responsiveness to external magnetic field. Small interfering RNA (siRNA) is an important candidate for gene therapy, because it can inhibit specific protein expression. The conjugation of siRNA onto MNPs has been widely studied.
Lee et al. developed a MNPs-based siRNA delivery system by conjugating thiolated siRNA on BSA-modified manganese-doped magnetism-engineered iron oxide (MnMEIO) nanoparticles through disulfide bonds ( Figure 4A ). 148 The system could selectively target to cancer cells under the help of RGD peptide, and siRNA was released when disulfide bond was broken by glutathione ( Figure 4B ). The suppression of green fluorescence protein (GFP) verified the therapeutic ability. Jiang et al. investigated the DNA/siRNA delivery efficiency by lipidoids-coated iron oxide nanoparticles with various particle sizes. 149 The results indicated that the 50~100 nm particles showed better DNA delivery activity and the size was not significant in siRNA delivery. However, both siRNA and DNA delivery efficiency could be enhanced by applying an external magnetic field. Besides siRNA, tumor suppressor protein gene, 150 and microRNA (miRNA) 151 are also used frequently in gene therapy. PEI, PEG and block copolymers were also commonly used to modify MNPs for gene delivery. 46, 152−154 
Magnetic Resonance Imaging (MRI)
MRI is considered as one of the most important diagnostic imaging tools in clinical applications owing to its noninvasive, high spatial resolution, strong soft tissue contrast and real-time monitoring features. 155 MNPs have been used as MRI contrast agents and could improve the inherently poor sensitivity of MR imaging. 43, 156 Studies indicated that the type and particle size can greatly influence the MRI contrast effects. 157 nanoparticles were examined with a superconducting quantum interference device (SQUID) magnetometer, and the mass magnetization of four type of nanoparticles were 110, 101, 99, and 85 (emu/mass of magnetic atoms) ( Figure 5 ). They also proved that 12-nm MnFe 2 O 4 nanoparticles had the highest mass magnetization compared with 6-nm and 9-nm nanoparticles. Magnetization of MNPs was size and type-dependent and higher magnetization could generate stronger T2 contrast in MRI. Studies indicated that MNPs are far more efficient than other MRI contrast agent, such as gadolinium (Gd 3+ )-based T1 contrast agents. One important factor is that MNPs could be easily functionalized with various surface coatings, which made them more biocompatible, easily selective uptake and easily be removed from the body. Dextran-coated iron oxide nanoparticles have been approved by FDA for MRI contrast agents. 46, 47 Huang et al. found that PVP-coated iron oxide nanoparticles exhibited good contrast enhancement. 159 Huang et al. also indicated that casein-coated iron oxide nanoparticles (CNIOs) were promising MRI contrast agents. 160 MRI is one of the upmost important diagnostics tools in clinical application. MNPs are a kind of special materials which can combine diagnostics with therapeutic agents in one platform, and the multifunctional diagnostic and therapeutic platform has attracted much attention.
Multifunctional MNPs for diagnosis and therapy
Combination of functions into one platform, such as combining delivery of therapeutic agents with hyperthermia and real-time monitoring, is more attractive and has been considered as a promising platform for cancer therapy. 161−165 Compared with single functional platform, multifunctional platform could not only realize diagnosis and treatment of cancer, but also monitor the drug delivery process. 166 The multifunctional platform is important in clinical use, and makes the therapy process become more convenient. Imaging guided drug delivery is one of the most important functions. Chen et al. developed iron oxide nanoparticles based drug delivery system named MFNEs nanoplatform, which was employed for simultaneous MRI/fluorescence imaging and therapeutic applications. 167 MFNE nanoplatform was composed of ellipsoidal Fe 3 O 4 cores and mesoporous silica shell with QDs ( Figure 6A ), which could accumulate at the cell membranes within short period. When the MFNEs were injected into the mouse subcutaneously and non-invasively detected with MRI, it can be clearly observed that the MFNEs diffused into the tumor ( Figure 6D ). Therefore, this nanoplatform has great potential for simultaneous cancer diagnosis and therapy. Medarova et al. attached siRNA to aminated-dextran coated MNPs with the functionalization of Cys5.5 probes and myrostelated polyarginine peptide (MPAP). 168 The MNPs-based probe showed fine resolution, unlimited depth penetration of MRI, high sensitivity and short acquisition times of optical imaging, and a substantial silencing in tumors was achieved. Specific delivery of anticancer drugs could significantly reduce side effects, MNPs based diagnostic and therapeutic platform could be guided by an external magnetic field. Besides, a series of specific ligands were introduced into the system to improve the specific target delivery. 169−171 Yu et al. reported Fe 5 C 2 nanoparticles based therapy probe. 172 The conjugation of affinity proteins (ZHER2： 342) onto Fe 5 C 2 nanoparticles induced a selective and higher level of cellular uptake, higher cell death rate under laser radiation, better contrast signal, and fantastic tumor therapy effect. Nasongkla et al. developed iron oxide nanoparticle-based target drug delivery system for theranostics application. 173 MNPs and DOX were co-loaded into the core of PEF-PLA micelles, and the specific ligand (cRGD) functionalized onto the micelle surface significantly increased the cell uptake efficiency. Zhou et al. developed IGF1 conjugated MNPs with DOX loading in the amphiphilic polymer shell, which could be guided by MRI and precise target IGF1R for pancreatic cancer therapy. 174 MNPs with good physical characteristics and proper functionalization were widely used in biomedical applications. Besides hyperthermia and drug delivery system, MNPs combined with gold 175, 176 and graphene 177, 178 could integrate of optical capability into a single platform, which further widen its application. The strong optical absorbance in the near infrared (NIR) region was useful in photothermal therapy. 179−184 Chen et al. developed iron oxide nanoparticles based dual functional photothermal therapy system, named IONP-Au 2 SNP core-satellite nanomediators. 67 Au 2 S nanoparticles were conjugated onto iron oxide nanoparticles surface to form core-satellite nanomediators, which possesses significantly photothermal effect and MRI contrast effect. MNPs could also be conjugated on gold nanorods, or embedded in the gold nanoshells, and a dual magnetic resonance/photoacoustic (MR/PA) imaging with magnetically targeted thermal therapy was formed. 185, 186 In recent years, graphene and graphene oxide have attracted significant interests in the area of biomedical applications. 187−189 Graphene based optical imaging agent for cancer diagnostic and photothermal therapy was investigated by researchers for the wide range of excitation and emission properties of graphene and graphene oxide. 190−192 Yang et al. designed a probe based on reduced graphene oxide (RGO)-iron oxide nanoparticle (IONP) nanocomposite with PEG functionality for multimodal imaging guided photothermal therapy. 178 Under the help of high NIR absorbance of graphene, magnetic property of iron oxide nanoparticles and external fluorescent Cy5, the nanocomposite could be used as contrast agents for fluorescence and MR imaging ( Figure 7A and B) , the MR imaging guided PTT treatment achieve ultra-efficient tumor ablation using a laser power density at 0.5 W/cm 2 . The nanocomposites also efficiently suppressed the cancer cell Figure 7C and D). Narayanan et al. reported that iron oxide nanoparticles (IONP) could be covalently attached to graphene oxide to form GO-IONP for multimodal fluorescence, MR imaging and hyperthermia of cells. 193 In a word, the easily modified MNPs are suitable for hyperthermia seeds, drug/gene delivery system, and other multifunctional diagnostic and therapeutic platform. Importantly, MNPs based platform is useful in cancer therapy.
Summary and perspectives
In this review, we outlined four synthesis methods of MNPs. Generally speaking, MNPs, synthesized by co-precipitation method, are relatively poor in size control compared with other three synthesis methods mentioned in the review. However, the large production by co-precipitation have attractive much attention. Each method exhibits their advantages. The appropriate surface modification could improve the drawbacks of MNPs and strongly widen their biomedical applications.
In further work, functionalized MNPs are still an important factor for biomedical applications. In this review, we have summarized the materials usually used to modify MNPs and hence widen the biomedical application of MNPs, including hyperthermia, drug/gene delivery, MRI contrast, and multifunctional diagnosis and therapy. However, there are still some problems to which should be paid much attention, including controllable particle size and particle shape, the long-term circulation and elimination of the MNPs in the body, and the side effect of MNPs induced during therapeutic process. We believe that these problems could be solved in the future, and hope that more MNPs based diagnostics and therapy system could be used in clinic and provide great contributions to human health soon.
